EUVIMEDEUVIMED entdecken
Crossref

Antioxidant and Neuroprotective Effects of Xanthohumol in an in Vitro Model of Parkinson’s Disease

Sıdıka Genç, Ali Taghizadehghalehjoughi, Esmanur Nigde, Kubra Karabulut, Yunus Emre Aydın, Ozlem Utme, Rafig Gurbanov

Neuro-Cell Molecular Research · 30.12.2025 · 2 (3) · 95-101

DOI: 10.66588/ncmr.v02i03.5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Cell Molecular Research, online erschienen am 30.12.2025. Verfasst von Sıdıka Genç und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the neuroprotective effects of Xanthohumol (XAN), on Parkinson’s disease and an in vitro model by focusing on PPAR-γ and oxidative stress. To establish a Parkinson's Disease (PD) model, SH-SY5Y cells were exposed to 200 µM 6-OHDA for 15 minutes. The SH-SY5Y cells were treated with different concentrations of XAN (50, 100, and 200 µg/mL). At the end of the experiment, cytotoxicity and Oxidative stress were assessed using the MTT assay, the total antioxidant capacity (TAC) and total oxidant status (TOS) assays, and the PPAR-γ assay. These results suggest that specific doses of XAN may have neuroprotective effects with potential relevance for the treatment of neurodegenerative diseases. The Parkinson's control group shows a decrease in cell viability of up to 50% in SH-SY5Y cells compared with the control group. XAN prevented 6-OHDA-induced apoptosis and increased cell viability in a dose-dependent manner. TAC and TOS analyses showed that 100 and 200 µg/mL XAN more effectively increased TAC capacity by 60% but caused a 30% decrease in TOS. In contrast, elevated PPAR-γ levels were measured in correlation with the MTT result. XAN results indicate that it may be part of the treatment strategy for Parkinson's disease.

Zitieren

APA

Genç, S., Taghizadehghalehjoughi, A., Nigde, E., Karabulut, K., Aydın, Y. E., Utme, O., & Gurbanov, R. (2025). Antioxidant and Neuroprotective Effects of Xanthohumol in an in Vitro Model of Parkinson’s Disease. Neuro-Cell Molecular Research, 2(3), 95-101. https://doi.org/10.66588/ncmr.v02i03.5

Vancouver

Genç S, Taghizadehghalehjoughi A, Nigde E, Karabulut K, Aydın YE, Utme O, et al. Antioxidant and Neuroprotective Effects of Xanthohumol in an in Vitro Model of Parkinson’s Disease. Neuro-Cell Molecular Research. 2025;2(3):95-101. doi:10.66588/ncmr.v02i03.5

BibTeX
@article{Gen2025,
  author = {Genç, Sıdıka and Taghizadehghalehjoughi, Ali and Nigde, Esmanur and Karabulut, Kubra and Aydın, Yunus Emre and Utme, Ozlem and Gurbanov, Rafig},
  title = {Antioxidant and Neuroprotective Effects of Xanthohumol in an in Vitro Model of Parkinson’s Disease},
  journal = {Neuro-Cell Molecular Research},
  year = {2025},
  volume = {2},
  number = {3},
  pages = {95--101},
  doi = {10.66588/ncmr.v02i03.5}
}
Kostenlos starten →